| abstract |
In some aspects, the disclosure relates to methods and compositions for modulation of miR- 122 expression in a cell or a subject. In some embodiments, methods and compositions described by the disclosure are useful for the treatment of liver-associated diseases (e.g., chronic liver disease, alcoholic liver disease). |